Skip to content

13F-HR filed by Twin Securities, Inc.

Twin Securities, Inc. filed this 13F-HR for the quarter ended 2019-09-30, filed 2019-11-14, with 11 holding rows worth $165,905,000.

Accession
0001172661-19-002337
Filed
2019-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2019

A holdings report, 11 entries on the cover page, a total value of $165,905,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $165,905,000 with VALUE read as thousands by filing date, 13F file number 028-11568. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CELGENE CORP151020104COM706,034$70,109,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM290,793$28,201,000thousands by filing date
ZAYO GROUP HLDGS INC COM98919V105Stock630,615$21,378,000thousands by filing date
ALLERGAN PLCG0177J108SHS119,786$20,159,000thousands by filing date
MELLANOX TECHNOLOGIES LTDM51363113COMMON STOCK141,136$15,467,000thousands by filing date
CVS Health Corporation126650100COM71,600$4,516,000thousands by filing datecall
Altria Group Inc02209S103COM104,672$4,281,000thousands by filing date
KRAFT HEINZ CO COM500754106Stock30,059$840,000thousands by filing date
ALTISOURCE ASSET MGMT CORP02153X108COM69,122$645,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM2,700$262,000thousands by filing datecall
CVS Health Corporation126650100COM752$47,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001172661-19-002337this filing2019-11-14acceptance time not in the bulk data set